Digital Breast Tomosynthesis DBT System Sales

Digital Breast Tomosynthesis (DBT) System Sales Market Outlook

The global Digital Breast Tomosynthesis (DBT) system sales market is projected to reach USD 4.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of 10.7% during the forecast period from 2025 to 2035. The increasing prevalence of breast cancer across the globe is a significant driving factor for the growth of this market. Additionally, advancements in technology, such as the development of high-resolution imaging systems and AI integration for enhanced diagnostic capabilities, are contributing to market expansion. Furthermore, rising awareness regarding the importance of early breast cancer detection and improved screening programs are also fostering market growth. The ongoing innovations in DBT technology are expected to enhance diagnostic accuracy and patient outcomes, making these systems more appealing to healthcare providers.

Growth Factor of the Market

The growth of the Digital Breast Tomosynthesis (DBT) system sales market is propelled by several factors that align with the evolving landscape of healthcare diagnostics. The shift towards personalized medicine and precision diagnostics has encouraged healthcare facilities to adopt advanced imaging technologies like DBT, which offer superior imaging capabilities compared to traditional mammography. Moreover, the rising incidence of breast cancer, alongside increased funding for women's health initiatives, has underscored the need for innovative diagnostic solutions. Technological advancements, such as the integration of artificial intelligence in DBT systems for enhanced image analysis and interpretation, have also played a critical role in pushing the market forward. Regulatory approvals and recommendations from health organizations advocating for breast cancer screening have further stimulated demand in the market. Additionally, the growing inclination towards outpatient procedures and the expansion of diagnostic centers are likely to bolster the adoption of DBT systems in various settings.

Key Highlights of the Market

• The market is forecasted to grow at a CAGR of 10.7% from 2025 to 2035.
• Technological advancements are driving the integration of AI in DBT systems, improving diagnostic accuracy.
• Increased funding for breast cancer awareness and screening programs is supporting market growth.
• Standalone and integrated DBT systems are gaining traction among healthcare providers.
• The rising prevalence of breast cancer globally is a significant factor impacting market demand.

By Product Type

Stationary DBT Systems:

Stationary DBT systems are often the backbone of breast imaging in large healthcare facilities, providing high-quality images with the capability for extensive analysis. These systems are designed for optimal performance in a controlled clinical environment, enabling physicians to conduct thorough examinations. Their robust design is geared towards delivering precise imaging results, which is critical for accurate diagnosis and treatment planning. As technology advances, stationary systems are becoming more versatile, incorporating features such as advanced imaging algorithms that improve the visualization of breast architecture. The investment in stationary DBT systems reflects a healthcare provider's commitment to offering state-of-the-art diagnostic services, which is driving their sales growth in the market.

Portable DBT Systems:

Portable DBT systems are revolutionizing breast imaging by offering flexibility and convenience, particularly in point-of-care settings. These systems are designed to be compact and lightweight, making them ideal for use in various environments, including remote locations and community health clinics. The advent of portable DBT technology has made breast cancer screening more accessible to underserved populations, thereby improving early detection rates. Furthermore, the ease of transport and operation of these systems allows healthcare providers to conduct screenings in diverse settings, meeting the growing demand for mobile healthcare solutions. The increasing focus on preventative care and the ability of portable systems to enhance accessibility are driving their adoption within the market.

Standalone DBT Systems:

Standalone DBT systems represent a pivotal segment of the market, designed specifically for dedicated breast imaging purposes. These systems function independently of conventional mammography systems, providing specialized capabilities tailored for enhanced breast cancer detection. Standalone DBT systems are equipped with advanced imaging technologies that allow for high-resolution 3D images of breast tissue, facilitating improved tumor detection rates and reducing false positives. Their standalone nature makes them suitable for specialized facilities focusing solely on breast health, thereby fostering a niche market for such systems. As healthcare providers increasingly prioritize early detection and patient-centered care, the demand for standalone DBT systems is expected to grow significantly.

Integrated DBT Systems:

Integrated DBT systems combine traditional mammography with digital breast tomosynthesis capabilities, creating a seamless workflow for healthcare providers. These systems are engineered to optimize space and resources within imaging facilities, allowing for streamlined operations. By integrating both imaging modalities, healthcare providers can offer comprehensive diagnostic solutions that enhance patient care. The integrated systems provide a complete diagnostic package, thus improving patient throughput and efficiency within imaging departments. Moreover, the ability to access both 2D and 3D imaging data from a single device is appealing to healthcare providers who wish to maximize their investment in technology while ensuring high-quality patient outcomes.

Upgraded DBT Systems:

Upgraded DBT systems are designed to enhance existing imaging technologies, providing improved functionalities and features that align with contemporary diagnostic needs. The upgrades often include advanced software algorithms, superior imaging receptors, and integration with AI-driven analytics, all aimed at improving diagnostic accuracy and workflow efficiency. Facilities that opt for upgraded systems benefit from enhanced resolution and faster processing times, which leads to better patient experiences. The continual evolution of technology in the healthcare sector has made upgrading existing systems a strategic move for many providers, allowing them to remain competitive and provide the best care possible. This trend also reflects the broader healthcare industry's emphasis on adopting cutting-edge technology to improve patient outcomes and operational efficiency.

By Application

Hospitals:

Hospitals represent a significant application segment for Digital Breast Tomosynthesis (DBT) systems, as they are major providers of breast cancer screening and diagnostic services. The comprehensive infrastructure in hospitals allows for the integration of advanced imaging technologies, facilitating large-scale screening programs. The high patient volume in hospitals necessitates the adoption of efficient imaging systems like DBT, which enhances diagnostic accuracy and reduces recall rates. Additionally, hospitals often have the resources to invest in the latest technologies, including training for staff and support for maintaining advanced equipment. As the healthcare landscape evolves towards more precise and less invasive diagnostic approaches, hospitals are likely to continue leading the way in DBT adoption.

Diagnostic Centers:

Diagnostic centers are increasingly becoming a focal point for the utilization of Digital Breast Tomosynthesis systems, driven by the growing demand for specialized imaging services. These centers are dedicated to providing imaging and diagnostic tests, making them ideal environments for the implementation of DBT technology. The rise in patient referrals for breast screenings has pushed diagnostic centers to upgrade their imaging capabilities, positioning themselves as leaders in women's health services. The ability to deliver quick results and accurate diagnoses attracts patients, thus bolstering the growth of these centers. Furthermore, the focus on early detection of breast cancer is pivotal for diagnostic centers, prompting continued investments in DBT technology.

Research Institutes:

Research institutes play a crucial role in advancing the field of breast imaging and cancer detection through the utilization of Digital Breast Tomosynthesis systems. These institutes conduct extensive studies and clinical trials aimed at improving diagnostic methodologies and patient outcomes. The integration of DBT technology in research settings enables the exploration of new applications and enhancements to existing imaging techniques. As research continues to validate the effectiveness of DBT in various scenarios, the findings can lead to broader adoption within clinical practices. Additionally, collaborations between research institutes and healthcare providers facilitate the rapid dissemination of innovative breast imaging technologies, driving the growth of the DBT market.

Others:

Other applications of Digital Breast Tomosynthesis systems include specialty clinics, mobile screening units, and community health initiatives that focus on breast cancer awareness and prevention. These applications highlight the versatility of DBT technology in diverse healthcare settings. Mobile screening units, in particular, are instrumental in reaching underserved populations, providing critical breast cancer screenings in areas with limited access to healthcare facilities. The flexibility of DBT systems allows these units to operate efficiently, delivering high-quality imaging to women who may otherwise forego screenings. Furthermore, community health initiatives that incorporate DBT technology emphasize the importance of early detection and education, promoting public health goals that contribute to market growth.

By User

Oncology Centers:

Oncology centers are pivotal users of Digital Breast Tomosynthesis systems, as they specialize in diagnosing and treating breast cancer. The advanced imaging capabilities provided by DBT technology are essential for oncologists to identify tumors accurately and assess their characteristics. As oncology centers often manage high-risk patients, the ability to utilize DBT to provide precise imaging results directly influences treatment decisions and patient outcomes. The integration of DBT systems into oncology practices enhances the diagnostic pathway, enabling earlier interventions and more targeted therapies. As cancer care continues to evolve towards personalized medicine, the demand for DBT systems in oncology settings is expected to rise.

Breast Care Clinics:

Breast care clinics, dedicated to comprehensive breast health services, are increasingly adopting Digital Breast Tomosynthesis systems to enhance their diagnostic capabilities. These clinics focus on prevention, early detection, and treatment of breast-related conditions, making them prime users of advanced imaging technologies. The utilization of DBT allows breast care specialists to provide optimal patient care through accurate and efficient screenings. Moreover, the combination of DBT with other breast health services reinforces the clinic's commitment to utilizing the latest advancements in technology for better health outcomes. The growing awareness and emphasis on breast health are driving the demand for DBT systems in these specialized clinics.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are adopting Digital Breast Tomosynthesis systems to facilitate outpatient procedures that include breast biopsies and other minimally invasive surgeries. The integration of DBT technology into ASCs enhances the accuracy of pre-operative assessments, allowing for better surgical planning and execution. With the healthcare industry shifting towards outpatient care models, the demand for DBT in ASCs is expected to grow, providing patients with immediate access to diagnostic services. Moreover, the ability to deliver quality care without the need for overnight hospital stays aligns with the evolving preferences of patients seeking convenience. This trend positions ASCs as significant users of DBT systems in the market.

Others:

In addition to the primary users such as oncology centers and breast care clinics, other entities leveraging Digital Breast Tomosynthesis systems include academic institutions, mobile health units, and governmental health programs. Academic institutions often utilize DBT technology for training and educational purposes, enabling the next generation of healthcare professionals to become proficient in advanced imaging techniques. Mobile health units extend the reach of breast cancer screening to underserved populations, emphasizing the vital role of DBT systems in community health initiatives. Furthermore, governmental health programs that advocate for breast cancer awareness and screening contribute to the wider adoption of DBT technology, thereby enhancing access to early detection services across diverse demographics.

By Technology

2D/3D Combination Systems:

2D/3D combination systems are gaining traction within the Digital Breast Tomosynthesis market due to their dual imaging capabilities. These systems allow healthcare providers to perform both traditional 2D mammography and advanced 3D tomosynthesis in a single examination. The combination enhances the diagnostic process, as the 2D images can provide contextual information that complements the detailed 3D views of breast tissue. This integrated approach leads to improved diagnostic accuracy and reduced recall rates, which is essential for patient satisfaction and clinical efficiency. As healthcare providers continue to seek innovative solutions that maximize diagnostic outcomes while minimizing patient anxiety, 2D/3D combination systems are expected to see robust growth.

3D Only Systems:

3D only systems represent a significant advancement in breast imaging technology, providing comprehensive 3D views of breast tissue without the need for 2D imaging. These systems utilize a series of low-dose X-ray images taken at different angles, which are then reconstructed into a 3D image for detailed analysis. The primary advantage of 3D only systems is their ability to produce clearer images of overlapping breast structures, which significantly enhances the detection of small tumors and reduces the likelihood of false positives. As the healthcare industry places increasing emphasis on accuracy and precision in cancer detection, 3D only systems are becoming a preferred choice among imaging facilities, driving their adoption in the market.

3D/4D Systems:

3D/4D systems are at the forefront of breast imaging technology, offering dynamic imaging capabilities that enhance the visualization of breast tissue. The inclusion of 4D imaging allows for real-time movement assessments, providing critical insights during procedures such as biopsies. These systems represent the pinnacle of imaging technology, combining high-resolution 3D imaging with the added dimension of time, which is particularly useful in evaluating breast lesions. As demand for precision diagnostics escalates, the adoption of 3D/4D systems is likely to increase, providing healthcare providers with advanced tools to improve patient outcomes and treatment plans.

Others:

The category of 'Others' in DBT technology encompasses emerging imaging modalities and hybrid systems that integrate other imaging techniques with tomosynthesis. Innovations in imaging technology often lead to the development of new solutions that enhance diagnostic capabilities and streamline workflows. These alternative systems may combine features such as contrast-enhanced imaging or integrate ultrasound capabilities, providing a more comprehensive approach to breast cancer detection. As research continues to evolve, the 'Others' category represents a dynamic segment of the market, which may see increased interest as healthcare providers seek to adopt the latest technologies for improved patient outcomes.

By Region

The North American market for Digital Breast Tomosynthesis (DBT) systems is anticipated to maintain its leadership position, driven by the high prevalence of breast cancer and robust healthcare infrastructure. With a market size projected to reach USD 2.0 billion by 2035, North America is capitalizing on technological innovation and widespread acceptance of advanced diagnostic solutions. A significant number of healthcare facilities in the region have already adopted DBT systems, reinforcing the commitment to early detection and enhanced patient care. The CAGR for the North American market is expected to be approximately 11.2%, reflecting the sustained investment in breast health technologies and the continuous push towards improving screening rates.

In Europe, the DBT systems market is rapidly expanding, projected to reach USD 1.5 billion by 2035. The region benefits from strong regulatory support for breast cancer screening programs and a growing awareness of the importance of early detection. Countries such as Germany, France, and the UK are at the forefront of adopting DBT technology, fostering collaborations between healthcare providers and medical technology firms. Moreover, the increasing emphasis on patient-centered care within European healthcare systems is driving investments in advanced imaging technologies. The European market is expected to grow at a CAGR of 9.5%, showcasing a clear trend towards integrating innovative imaging solutions into routine breast cancer screening practices.

Opportunities

The Digital Breast Tomosynthesis (DBT) system sales market is poised for significant opportunities, particularly as healthcare organizations continue to recognize the benefits of advanced imaging technology in breast cancer detection. One of the primary opportunities stems from the increasing focus on early detection and preventative care in healthcare systems worldwide. As awareness regarding breast cancer rises, more women are seeking regular screenings, creating a demand for efficient and accurate imaging solutions. Additionally, the expansion of telemedicine and remote healthcare initiatives presents a unique opportunity for DBT systems to be integrated into mobile screening units, allowing for access to underserved populations. By leveraging these technological advancements, the market can reach a broader patient base, increasing sales potential for DBT systems.

Furthermore, the ongoing research and development in imaging technologies are likely to unlock new avenues for growth in the DBT systems market. Innovations such as AI-driven analytics and machine learning algorithms are becoming increasingly prominent in imaging systems, leading to improved diagnostics and patient outcomes. Companies that invest in R&D to enhance their DBT offerings can gain a competitive edge, positioning themselves as leaders in the market. Collaborations between technology firms and healthcare providers can also foster the development of customized solutions that address specific diagnostic needs, paving the way for more comprehensive applications of DBT technology in clinical practice.

Threats

Despite the growth prospects, the Digital Breast Tomosynthesis (DBT) systems market faces several threats that could potentially hinder its expansion. One of the primary threats is the high cost associated with acquiring and maintaining advanced imaging systems, which may deter smaller healthcare facilities from investing in DBT technology. This financial barrier can create disparities in access to cutting-edge diagnostic tools, particularly in economically disadvantaged regions. Furthermore, the rapidly evolving technology landscape poses a challenge, as healthcare providers must continually upgrade their systems to remain competitive. The high rate of technological obsolescence may lead to increased operational costs and resource allocation that could impact the overall profitability of DBT systems.

Additionally, the market is susceptible to regulatory changes and reimbursement policies that can impact the adoption of DBT technology. Stringent regulations might slow down the approval processes for new systems, and fluctuations in reimbursement rates for imaging services can deter healthcare providers from investing in innovative technologies. The reliance on insurance coverage for breast cancer screenings also raises concerns, as variations in policy can influence patient access to DBT systems. These factors underline the importance of strategic planning and adaptability for companies operating in this dynamic market, as they navigate potential threats that could affect their growth trajectory.

Competitor Outlook

• Hologic Inc.
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Fujifilm Medical Systems
• Carestream Health
• Canon Medical Systems
• Medtronic
• Konica Minolta
• Agfa HealthCare
• Shenzhen Anke High-tech Co., Ltd.
• Clarius Mobile Health
• imaginAb, Inc.
• Bracco Imaging S.p.A.
• Neusoft Medical Systems Co., Ltd.

The competitive landscape of the Digital Breast Tomosynthesis (DBT) system sales market is characterized by the presence of several prominent players who are continuously striving to innovate and expand their product offerings. Hologic Inc. remains a market leader, recognized for its pioneering efforts in developing DBT technology and its commitment to enhancing women's health services. The company's extensive portfolio includes advanced imaging systems that feature integrated software for improved interpretation and analysis. Hologic's focus on research and development ensures that it remains at the forefront of technological advancements in the field, allowing it to cater to a wide range of healthcare providers globally.

GE Healthcare and Siemens Healthineers also play significant roles in the DBT market, leveraging their vast experience in medical imaging technology. GE Healthcare is known for its innovative imaging solutions that combine artificial intelligence with traditional imaging techniques, enhancing the accuracy and efficiency of breast cancer screenings. On the other hand, Siemens Healthineers has made significant strides in integrating digital solutions with its imaging devices, providing healthcare professionals with tools that facilitate improved patient care. Both companies are dedicated to expanding their market presence through strategic partnerships and collaborations with healthcare organizations to further enhance their product offerings.

Philips Healthcare and Fujifilm Medical Systems represent other key players in the DBT market, each bringing unique strengths to the competitive landscape. Philips Healthcare focuses on patient-centered solutions, integrating advanced imaging technology with streamlined workflows to improve the overall diagnostic experience. Fujifilm Medical Systems, with its strong emphasis on digital imaging and information technologies, is innovating to provide high-quality imaging solutions that meet the needs of modern healthcare. Both companies continue to invest in research and development to enhance their imaging capabilities, aiming to address the growing demand for accurate breast cancer detection.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hologic Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Konica Minolta
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 imaginAb, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Agfa HealthCare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Carestream Health
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Philips Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Bracco Imaging S.p.A.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Canon Medical Systems
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Clarius Mobile Health
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fujifilm Medical Systems
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Neusoft Medical Systems Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shenzhen Anke High-tech Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Digital Breast Tomosynthesis DBT System Sales Market, By User
    • 6.1.1 Oncology Centers
    • 6.1.2 Breast Care Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Others
  • 6.2 Digital Breast Tomosynthesis DBT System Sales Market, By Technology
    • 6.2.1 2D/3D Combination Systems
    • 6.2.2 3D Only Systems
    • 6.2.3 3D/4D Systems
    • 6.2.4 Others
  • 6.3 Digital Breast Tomosynthesis DBT System Sales Market, By Application
    • 6.3.1 Hospitals
    • 6.3.2 Diagnostic Centers
    • 6.3.3 Research Institutes
    • 6.3.4 Others
  • 6.4 Digital Breast Tomosynthesis DBT System Sales Market, By Product Type
    • 6.4.1 Stationary DBT Systems
    • 6.4.2 Portable DBT Systems
    • 6.4.3 Standalone DBT Systems
    • 6.4.4 Integrated DBT Systems
    • 6.4.5 Upgraded DBT Systems

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Digital Breast Tomosynthesis DBT System Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Digital Breast Tomosynthesis DBT System Sales market is categorized based on

By Product Type

• Stationary DBT Systems
• Portable DBT Systems
• Standalone DBT Systems
• Integrated DBT Systems
• Upgraded DBT Systems

By Application

• Hospitals
• Diagnostic Centers
• Research Institutes
• Others

By User

• Oncology Centers
• Breast Care Clinics
• Ambulatory Surgical Centers
• Others

By Technology

• 2D/3D Combination Systems
• 3D Only Systems
• 3D/4D Systems
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Hologic Inc.
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Fujifilm Medical Systems
• Carestream Health
• Canon Medical Systems
• Medtronic
• Konica Minolta
• Agfa HealthCare
• Shenzhen Anke High-tech Co., Ltd.
• Clarius Mobile Health
• imaginAb, Inc.
• Bracco Imaging S.p.A.
• Neusoft Medical Systems Co., Ltd.